Related Experiment Video
Updated: Dec 11, 2025
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
Head and neck mucosal melanoma: The United Kingdom national guidelines
Pablo Nenclares1, Derfel Ap Dafydd1, Izhar Bagwan2
1Royal Marsden Hospital NHS Foundation Trust, London, UK.
Abstract:
The United Kingdom head and neck mucosal melanoma guideline development group used an evidence-based systematic approach to make recommendations in key areas of uncertainty in the field, including accurate diagnosis and staging; the appropriate treatment pathway including surgery, adjuvant radiation and new systemic treatments, such as targeted agents and immunotherapy; and the surveillance of patients after treatment. The guidelines were sent for international peer review and have been accredited by the National Institute for Health and Care Excellence. A summary of key recommendations is presented. The full documents are available on the Melanoma Focus website (https://melanomafocus.com/activities/mucosal-guidelines/mucosal-melanoma-resources/).
Insights
This study outlines evidence-based guidelines for head and neck mucosal melanoma, covering diagnosis, treatment pathways including surgery and systemic therapies, and patient surveillance. These recommendations aim to improve patient outcomes for this rare cancer.
Area of Science:
- Oncology
- Head and Neck Surgery
- Evidence-Based Medicine
Background:
- Head and neck mucosal melanoma is a rare and aggressive malignancy.
- There is significant uncertainty regarding optimal management strategies.
- Existing guidelines require updating to reflect recent advancements.
Purpose of the Study:
- To develop evidence-based clinical practice guidelines for head and neck mucosal melanoma.
- To provide recommendations on diagnosis, staging, treatment, and surveillance.
- To address key areas of uncertainty in the management of this disease.
Main Methods:
- A systematic, evidence-based approach was employed by a multidisciplinary guideline development group.
- Key areas of uncertainty were identified and addressed through rigorous literature review.
- Recommendations were formulated based on the synthesized evidence.
Main Results:
- The guidelines provide recommendations on accurate diagnosis and staging.
- The guidelines detail appropriate treatment pathways, including surgery, adjuvant radiation, and novel systemic treatments (targeted agents and immunotherapy).
- Recommendations for post-treatment patient surveillance are included.
Conclusions:
- The developed guidelines offer a comprehensive, evidence-based framework for managing head and neck mucosal melanoma.
- These guidelines have undergone international peer review and accreditation by the National Institute for Health and Care Excellence.
- The full guidelines are accessible for clinical implementation and further research.
